Adachi Yoshiaki, Chandrasekar Nirmala, Kin Yoshiaki, Lakka Sajani S, Mohanam Sanjeeva, Yanamandra Niranjan, Mohan Pamarthi M, Fuller Gregory N, Fang Bingliang, Fueyo Juan, Dinh Dzung H, Olivero William C, Tamiya Takashi, Ohmoto Takashi, Kyritsis Anthanassios P, Rao Jasti S
Department of Neurological Surgery, Okayama University Medical School, 2-5-1 shikata-cho, Okayama, 700-8558, Japan.
Oncogene. 2002 Jan 3;21(1):87-95. doi: 10.1038/sj.onc.1204999.
Our previous studies showed that the urokinase-type plasminogen activator receptor (uPAR) and the p16 tumor suppressor gene play a significant role in glioma invasion. We expected that downregulation of uPAR and overexpression of p16 using a bicistronic vector might cause a additive and cooperative effect in the suppression of glioma invasion and growth. The bicistronic construct (Ad-uPAR/p16)-infected glioblastoma cell lines had significantly lower levels of uPAR and higher levels of p16 than controls. Cell cycle analysis showed the bicistronic vector caused G0/G1 arrest of the cell cycle. In vitro glioblastoma cell growth and invasiveness were inhibited in Ad-uPAR/p16-infected cells compared with controls. Ad-uPAR/p16 suppressed the tumor growth of glioblastoma cell lines in an ex vivo intracerebral tumor model and an in vivo subcutaneous tumor model. Our results support the therapeutic potential of simultaneously targeting uPAR and p16 in the treatment of gliomas.
我们之前的研究表明,尿激酶型纤溶酶原激活物受体(uPAR)和p16肿瘤抑制基因在胶质瘤侵袭中发挥重要作用。我们预期,使用双顺反子载体下调uPAR并上调p16可能在抑制胶质瘤侵袭和生长方面产生累加和协同效应。与对照相比,双顺反子构建体(Ad-uPAR/p16)感染的胶质母细胞瘤细胞系中uPAR水平显著降低,p16水平升高。细胞周期分析显示双顺反子载体导致细胞周期的G0/G1期阻滞。与对照相比,Ad-uPAR/p16感染的细胞中,体外胶质母细胞瘤细胞的生长和侵袭能力受到抑制。在离体脑内肿瘤模型和体内皮下肿瘤模型中,Ad-uPAR/p16抑制了胶质母细胞瘤细胞系的肿瘤生长。我们的结果支持在胶质瘤治疗中同时靶向uPAR和p16的治疗潜力。